Anne I. Goldman

6.8k citations

73 papers · 5.1k indexed · 1 hit paper · h-index 36

Hematology top 0.5%
Oncology top 2%
Public Health, Environmental and Occupational Health top 2%
Genetics top 1%
Molecular Biology

Co-authors: Norma K.C. Ramsay Clara D. Bloomfield B. J. Kennedy John H. Kersey Glauco Frizzera John Kersey William Krivit Philip B. McGlave
Topics: Hematopoietic Stem Cell Transplantation (17 papers)Acute Lymphoblastic Leukemia research (8 papers)Acute Myeloid Leukemia Research (7 papers)
Cited by: Hematology Genetics Oncology
Journals: New England Journal of Medicine The Lancet JAMA
Partner nations: United States Netherlands United Kingdom

In The Last Decade

Anne I. Goldman

73 papers receiving 4.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

2002 743 citations John E. Wagner, Todd E. DeFor et al. Blood profile →

Peers

Countries citing papers authored by Anne I. Goldman

Since Specialization

Citations

This map shows the geographic impact of Anne I. Goldman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne I. Goldman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne I. Goldman more than expected).

Fields of papers citing papers by Anne I. Goldman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne I. Goldman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne I. Goldman. The network helps show where Anne I. Goldman may publish in the future.

Co-authorship network of co-authors of Anne I. Goldman

This figure shows the co-authorship network connecting the top 25 collaborators of Anne I. Goldman. A scholar is included among the top collaborators of Anne I. Goldman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne I. Goldman. Anne I. Goldman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase 1/2 randomized, placebo-control trial of palifermin to prevent graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT) 2006 ·Blood ·Bruce R. Blazar,Daniel J. Weisdorf,Todd E. DeFor,Anne I. Goldman,Thomas Braun,S. Silver,James L.M. Ferrara	109
2	Palifermin (a RHUKGF molecule) is safe and well tolerated in patients with hematologic malignancies (HM) undergoing high-dose chemoradiotherapy (HD-CRT) followed by allogeneic hematopoietic stem cell transplantation (HSCT) 2005 ·Biology of Blood and Marrow Transplantation ·Bruce R. Blazar,Daniel J. Weisdorf,Todd E. DeFor,Anne I. Goldman,S. Silver,James L.M. Ferrara	3
3	Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95 2003 ·Experimental Hematology ·Bianling Liu,(unknown),Ian D. Lewis,Anne I. Goldman,John E. Wagner,Johannes C.M. van der Loo	31
4	Optimization of Gene Transfer into Primitive Human Hematopoietic Cells of Granulocyte-Colony Stimulating Factor–Mobilized Peripheral Blood Using Low-Dose Cytokines and Comparison of a Gibbon Ape Leukemia Virus Versus an RD114-Pseudotyped Retroviral Vector 2002 ·Human Gene Therapy ·Johannes C.M. van der Loo,(unknown),Anne I. Goldman,Shannon M. Buckley,(unknown)	17
5	Optimal continuous sequential boundaries for monitoring toxicity in clinical trials: a restricted search algorithm 2001 ·Statistics in Medicine ·Anne I. Goldman,Peter J. Hannan	15
6	Effects of phenytoin on cocaine self-administration in humans1Portions of this report were presented at the 59th Annual Scientific Meeting of the College on the Problems of Drug Dependence, Nashville, June 1997.1 1999 ·Drug and Alcohol Dependence ·Mehmet Sofuoglu,Paul R. Pentel,Robin Bliss,Anne I. Goldman,Dorothy K. Hatsukami	16
7	Cotinine: effects with and without nicotine 1998 ·Psychopharmacology ·Dorothy Hatsukami,Paul R. Pentel,Joni Jensen,David Nelson,Sharon Allen,Anne I. Goldman,(unknown)	35
8	Analysis of failure times for multiple infections following bone marrow transplantation: an application of the multiple failure time proportional hazards model 1998 ·Statistics in Medicine ·Peter J. Hannan,Xiao Ou Shu,Daniel J. Weisdorf,Anne I. Goldman	6
9	Response of CD4 Lymphocytes and Clinical Consequences of Treatment Using ddI or ddC In Patients with Advanced HIV Infection 1996 ·Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology ·Anne I. Goldman,Bradley P. Carlin,Lawrence R. Crane,Cynthia A. Launer,Joyce A. Korvick,Lawrence Deyton,Donald I. Abrams	43
10	Insights from monitoring the CPCRA didanosine/zalcitabine trial. Terry Beirn Community Programs for Clinical Research on AIDS. 1995 ·PubMed ·(unknown),(unknown),Anne I. Goldman,(unknown),Cynthia A. Launer,Joyce A. Korvick,Donald I. Abrams	7
11	Insights from monitoring the CPCRA didanosine/zalcitabine trial 1995 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Thomas R. Fleming,(unknown),Anne I. Goldman,David L. DeMets,Cynthia A. Launer,Joyce A. Korvick,(unknown)	11
12	A Comparative Trial of Didanosine or Zalcitabine after Treatment with Zidovudine in Patients with Human Immunodeficiency Virus Infection 1994 ·New England Journal of Medicine ·Donald I. Abrams,Anne I. Goldman,Cynthia A. Launer,Joyce A. Korvick,James D. Neaton,Lawrence R. Crane,(unknown),Steven Wakefield,K Muth,(unknown),David L. Cohn,(unknown),Roberta Luskin‐Hawk,Norman Markowitz,James Sampson,Melanie Thompson,Lawrence Deyton	150
13	The cure model and time confounded risk in the analysis of survival and other timed events 1991 ·Journal of Clinical Epidemiology ·Anne I. Goldman	15
14	Allogeneic and Autologous Bone Marrow Transplantation for Acute Lymphoblastic Leukemia 1990 ·Hämatologie und Bluttransfusion ·Daniel Weisdorf,N. K. C. Ramsay,Tucker W. LeBien,William C. Woods,(unknown),Mark Nesbit,Daniel A. Vallera,Fatih M. Uckun,Anne I. Goldman,(unknown),P. B. Mcglave,David D. Hurd,R Haake,John Kersey	4
15	Allogeneic bone marrow transplantation for acute leukaemia: comparative outcomes for adults and children 1988 ·British Journal of Haematology ·Daniel Weisdorf,Philip B. McGlave,(unknown),Wesley J. Miller,Mark Nesbit,William G. Woods,Anne I. Goldman,(unknown),John H. Kersey	26
16	Four- and five-year follow-up results from four seventh-grade smoking prevention strategies 1988 ·Journal of Behavioral Medicine ·David M. Murray,(unknown),Anne I. Goldman,Phyllis L. Pirie,Russell V. Luepker	188
17	Smokeless tobacco use among ninth graders in a north-central metropolitan population: Cross-sectional and prospective associations with age, gender, race, family structure, and other drug use 1988 ·Preventive Medicine ·David M. Murray,L Roche,Anne I. Goldman,(unknown)	17
18	Issues in designing sequential stopping rules for monitoring side effects in clinical trials 1987 ·Controlled Clinical Trials ·Anne I. Goldman	22
19	Central nervous system involvement in acute nonlymphocytic leukemia 1987 ·The American Journal of Medicine ·B. A. Peterson,Richard D. Brunning,Clara D. Bloomfield,David D. Hurd,(unknown),Grace Peng,Anne I. Goldman	23
20	Graft‐versus‐host disease prophylaxis with anti‐T‐cell monoclonal antibody OKT3, prednisone and methotrexate in allogeneic bone‐marrow transplantation 1985 ·British Journal of Haematology ·A.H. Filipovich,(unknown),John H. Kersey,P. B. Mcglave,Norma K.C. Ramsay,Anne I. Goldman,Gideon Goldstein	19

About Anne I. Goldman

Anne I. Goldman is a scholar working on Hematology, Family Practice and Statistics and Probability, having authored 73 papers that have together received 5.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (17 papers), Acute Lymphoblastic Leukemia research (8 papers) and Acute Myeloid Leukemia Research (7 papers). The work is most often cited by research in Hematology (1.9k citations), Genetics (703 citations) and Oncology (1.2k citations). Anne I. Goldman has collaborated with scholars based in United States, Netherlands and United Kingdom. Frequent co-authors include Norma K.C. Ramsay, Clara D. Bloomfield, B. J. Kennedy, John H. Kersey, Glauco Frizzera, John Kersey, William Krivit, Philip B. McGlave, B. A. Peterson and Daniel J. Weisdorf. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact